Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTIMIL: Milrinone for DCI Prevention in Severe SAH
NCT04282629Phase 2Recruiting
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Jul 2021
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of milrinone in aneurysmal subarachnoid hemorrhage (SAH), sponsored by Centre hospitalier universitaire de Toulouse. Started Jul 2021; status: recruiting.
02
Drugs
milrinone
03
Conditions
aneurysmal subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NCT04282629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04282629.